Changes for Caffeine and Caffeine Containing Ingredients
Following a safety review on the ingredient caffeine, an amendment [...]
Updates to the Permissible Indications Determination
The TGA has advised us that updates to the Therapeutic Goods [...]
Adulteration Risk in Therapeutic Goods
The Macquarie Dictionary defines adulterate as: ‘to debase by adding [...]
Using ‘natural’ in advertising
The TGA has released guidance on the use of the [...]
TGA Fee Increase 1 July 2019
TGA fees will increase by 2.05% (subject to rounding) as [...]
How to declare $0 turnover through TBS
TGA Annual Charge Exemption (ACE) - How to declare $0 [...]
Understanding the Permissible Indication Determination (2019)
The TGA has just released the new and updated instrument, Therapeutic [...]
Overall presentation of products
An issue that keeps presenting with permitted indications is that [...]
Updates to Label Statements
The Permissible Indications Determination requires certain label statements, depending on [...]
Indications for Pregnancy and Foetal development
Permitted indications for Pregnancy Supplements Recent communication from the TGA [...]